CVE:NVO Novo Resources Corp. (NVO.V) (NVO) Stock Price, News & Analysis → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free NVO Stock Alerts C$2.38 -0.01 (-0.42%) (As of 12/31/2020) Add Compare Share Share Today's RangeC$2.37▼C$2.4450-Day RangeC$2.38▼C$2.3852-Week RangeC$1.41▼C$4.16Volume311,570 shsAverage Volume273,252 shsMarket CapitalizationC$548.24 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Novo Resources Corp. (NVO.V) alerts: Email Address Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. About Novo Resources Corp. (NVO.V) Stock (CVE:NVO)Novo Resources Corp., together with its subsidiaries, engages in evaluating, acquiring, and exploring natural resource properties in Canada, Australia, and the United States. It primarily explores for gold deposits. The company primarily focuses on the Egina and Beatons Creek projects in the Pilbara region of Western Australia. It also holds interest in the Mt. Elsie project that consists of three exploration licenses covering an area of approximately 19 square kilometers located in the north-east of Nullagine, Western Australia. The company was formerly known as Galliard Resources Corp. and changed its name to Novo Resources Corp. in June 2011. Novo Resources Corp. was incorporated in 2009 and is headquartered in Vancouver, Canada.Read More NVO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NVO Stock News HeadlinesApril 24, 2024 | msn.comWhat Are Pricing Strategies for Ozempic And Wegovy With Potential Medicare Coverage Expansion? Senate Committee Questions Novo NordiskApril 24, 2024 | msn.comNovo Nordisk comes under Senate probe over pricing of weight loss drugsApril 25, 2024 | Crypto Swap Profits (Ad)He Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.April 22, 2024 | seekingalpha.comNovo Nordisk Remains The Better Buy After A Moderate PullbackApril 18, 2024 | msn.comGerman Authority Gives Go Ahead To Novo Nordisk's Small Bolt On Acquisition As Danish Firm Seeks To Build Heart Drugs PipelineApril 18, 2024 | yahoo.comGerman watchdog approves Novo's acquisition of Cardior PharmaceuticalsApril 17, 2024 | americanbankingnews.comNovo Resources Corp. (NVO.V) (CVE:NVO) Shares Down 0.4% March 29, 2024 | juniorminingnetwork.comKORE Appoints New Chief Financial Officer and DirectorApril 25, 2024 | Crypto Swap Profits (Ad)He Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.March 27, 2024 | msn.comBernie Sanders Calls On Novo Nordisk To Lower Cost Of Ozempic And WegovyMarch 25, 2024 | msn.comNovo Nordisk Boosts Cardiovascular Pipeline With $1.1 Bln Purchase of Cardior Pharmaceuticals -- UpdateMarch 21, 2024 | msn.comWegovy's Success - Medicare Contemplates Covering Novo Nordisk's Semaglutide For Heart HealthMarch 16, 2024 | msn.comNovo Nordisk's weight loss drug Wegovy could soon be covered by MedicareMarch 11, 2024 | juniorminingnetwork.comLIBERO COPPER SECURES $2.86M FINANCINGMarch 9, 2024 | msn.comFDA Approves Novo Nordisk’s Wegovy for Heart Disease Risk Reduction A Game-Changer for Obesity TreatmentMarch 9, 2024 | msn.comNovo Nordisk says its weight loss drug Wegovy is going to ChinaMarch 8, 2024 | msn.comNovo Nordisk’s Wegovy Wins US Approval as Heart TreatmentMarch 8, 2024 | msn.comUPDATE 1-FDA approves Novo Nordisk's Wegovy for use in reducing heart attack risksMarch 7, 2024 | msn.comNovo Nordisk Shares Surge After Early Trial Shows New Obesity Drug Could Outperform WegovyMarch 7, 2024 | msn.comNovo Nordisk expects Wegovy approval in China this year: reportMarch 7, 2024 | msn.comNovo Nordisk stock spikes 10% to record high to eclipse Tesla market capMarch 7, 2024 | msn.comNovo Nordisk to present early drug trial data, Wegovy supply updateMarch 7, 2024 | msn.comNovo Nordisk’s New Obesity Pill Beats Wegovy In Early TrialFebruary 28, 2024 | seekingalpha.comNovo Nordisk, A Very Healthy Pharma StalwartFebruary 12, 2024 | msn.comNovo Nordisk's controlling shareholder plans to invest up to $7 bln a year by 2030 - FTFebruary 10, 2024 | news.yahoo.comNovo Nordisk settles two lawsuits over copycat versions of Ozempic and WegovyFebruary 6, 2024 | msn.comNovo Nordisk's parent to buy Catalent for $16.5 billion to boost Wegovy supplySee More Headlines Receive NVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Novo Resources Corp. (NVO.V) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorBasic Materials Industry Industrial Metals & Minerals Sub-IndustryN/A Current SymbolCVE:NVO CUSIPN/A CIKN/A Webwww.novoresources.com Phone604-562-4854FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio11.62 Current Ratio2.78 Quick Ratio2.57 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.22 per share Price / Cash Flow10.77 Book ValueC$1.38 per share Price / Book1.72Miscellaneous Outstanding Shares230,354,000Free FloatN/AMarket CapC$548.24 million OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesDr. Quinton Todd Hennigh (Age 53)Chairman & Pres Comp: $364.38kMr. Robert HumphrysonCEO & DirectorMr. Ronan Sabo-WalshCFO & Corp. Sec.Mr. Leonidas Karabelas (Age 41)VP of Corp. Communications Ms. Kas De LucaGen. Mang. of ExplorationMr. Alwin van RoijSr. Exploration GeologistMore ExecutivesKey CompetitorsKlondex MinesTSE:KDXGT GoldCVE:GTTNoront ResourcesCVE:NOTMaverix MetalsCVE:MMXTeck ResourcesTSE:TECK.AView All Competitors NVO Stock Analysis - Frequently Asked Questions How have NVO shares performed in 2024? Novo Resources Corp. (NVO.V)'s stock was trading at C$2.38 at the beginning of 2024. Since then, NVO stock has increased by 0.0% and is now trading at C$2.38. View the best growth stocks for 2024 here. What other stocks do shareholders of Novo Resources Corp. (NVO.V) own? Based on aggregate information from My MarketBeat watchlists, some companies that other Novo Resources Corp. (NVO.V) investors own include Pretium Resources (PVG), Ivanhoe Mines (IVN), Pretium Resources (PVG), Gold Standard Ventures (GSV), Harmony Gold Mining (HMY), First Majestic Silver (AG), Yamana Gold (AUY), Barrick Gold (GOLD) and Alexco Resource (AXU). How do I buy shares of Novo Resources Corp. (NVO.V)? Shares of NVO stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:NVO) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldPrepare for a recession unlike any otherAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Resources Corp. (NVO.V) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
